TRPM4 and ischemia: The reduction in brain swelling with no effect on infarct volume observed here is similar to our recent report with the same model of severe ischemia, in which we evaluated multiple pharmacological treatments and gene deletions targeting SUR1-TRPM4 and NCX1 [28].